Main Session
Sep
28
SS 21 - Immuno-Radiotherapy and Liquid Biomarkers in Gynecologic Cancer: Toward Precision Care
212 - Long-Term Outcomes of Definitive Chemoradiotherapy Plus Toripalimab for Locally Advanced Cervical Cancer: A Single-Center Phase II Trial with Integrated Pretreatment Transcriptomic Correlatives
Presenter(s)
Yuan Jie Cao, MD, PhD - Tianjin Medical University Cancer Institute and Hospital, Tian Jin, Tian Jin